These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2567019)

  • 1. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors.
    Gureje O
    Psychol Med; 1989 Feb; 19(1):121-8. PubMed ID: 2567019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.
    Mukherjee S; Rosen AM; Cardenas C; Varia V; Olarte S
    Arch Gen Psychiatry; 1982 Apr; 39(4):466-9. PubMed ID: 6121547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
    Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
    Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of tardive dyskinesia in a clinic population.
    Fleischhauer J; Kocher R; Hobi V; Gilsdorf U
    Psychopharmacology Suppl; 1985; 2():162-72. PubMed ID: 2860658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients.
    Sramek J; Roy S; Ahrens T; Pinanong P; Cutler NR; Pi E
    Hosp Community Psychiatry; 1991 Jun; 42(6):590-2. PubMed ID: 1677921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital.
    Ko GN; Zhang LD; Yan WW; Zhang MD; Buchner D; Xia ZY; Wyatt RJ; Jeste DV
    Am J Psychiatry; 1989 Mar; 146(3):387-9. PubMed ID: 2563929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
    Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
    Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia in schizophrenics. Prevalence, distribution and relationship to neurological "soft" signs in Nigerian patients.
    Gureje O
    Acta Psychiatr Scand; 1987 Nov; 76(5):523-8. PubMed ID: 2893513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia in elderly psychiatric patients: a 5-year study.
    Yassa R; Nastase C; Dupont D; Thibeau M
    Am J Psychiatry; 1992 Sep; 149(9):1206-11. PubMed ID: 1354413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population.
    Morgenstern H; Glazer WM; Gibowski LD; Holmberg S
    J Chronic Dis; 1987; 40(4):319-27. PubMed ID: 2881941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.